Haemonetics (NYSE:HAE) Coverage Initiated at Robert W. Baird

Analysts at Robert W. Baird initiated coverage on shares of Haemonetics (NYSE:HAE – Get Free Report) in a report issued on Thursday, MarketBeat reports. The firm set an “outperform” rating and a $87.00 price target on the medical instruments supplier’s stock. Robert W. Baird’s target price indicates a potential upside of 17.62% from the company’s […]

Leave a Reply

Your email address will not be published.

Previous post UBS Group Lowers General Mills (NYSE:GIS) Price Target to $49.00
Next post Bank of America Has Lowered Expectations for General Mills (NYSE:GIS) Stock Price